Hierarchical composite outcomes in acute ischaemic stroke with large infarct: a win ratio analysis of the TENSION trial
Open Access
- 2 June 2026
- journal article
- research article
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (6)
Abstract
Introduction: Traditional endpoints in acute ischaemic stroke trials, most commonly the mRS, incompletely capture the full spectrum of patient outcomes. The win ratio (WR) is a hierarchically structured composite outcome measure that prioritises endpoints according to clinical importance. In this study, we applied win statistics to investigate which components drive the overall treatment effect. Patients and methods: Of 253 patients in the TENSION (Efficacy and safety of ThrombEctomy iN Stroke with extended leSION and extended time window) trial, 125 were randomised to EVT + BMT and 128 to BMT alone. Endpoints were ranked hierarchically: (1) time to death, (2) mRS at 12 months, (3) occurrence of any serious adverse event and (4) EuroQOL 5-dimension scores at 12 months. Outcomes were analysed using win statistics. Results: The overall WR was 1.61 (95% CI, 1.19–2.18; P = .002), indicating a relative frequency of wins for EVT + BMT of approximately 60% among untied pairwise comparisons. The win difference was 22.8% (95% CI, 8.3%–36.3%; P = .002), of which 15.7% were attributable to survival. Win ratios were consistent across prespecified subgroups, including both sexes, age ≤ 80 years, baseline mRS 0–1, conscious patients, ASPECTS 5 and M1 occlusions. Discussion: The WR provides an informative complement to conventional mRS-based analyses in acute ischaemic stroke trials. Our hierarchical composite outcome analysis demonstrated how ordering of hierarchical components affects the resulting estimates, with the predominant treatment effect in TENSION being driven by improved survival. Conclusion: These findings support the complementary use of hierarchical composite outcomes in future neurointerventional trials.Keywords
Funding Information
- EU Horizon 2020 research and innovation programme (754640)
This publication has 35 references indexed in Scilit:
- A win ratio approach to comparing continuous non‐normal outcomes in clinical trialsPharmaceutical Statistics, 2016
- Making Sense of Statistics in Clinical Trial ReportsJACC, 2015
- Randomized Assessment of Rapid Endovascular Treatment of Ischemic StrokeNew England Journal of Medicine, 2015
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging SelectionNew England Journal of Medicine, 2015
- An Improved Method for Simple, Assumption-Free Ordinal Analysis of the Modified Rankin Scale Using Generalized Odds RatiosInternational Journal of Stroke, 2014
- A Simple, Assumption-Free, and Clinically Interpretable Approach for Analysis of Modified Rankin OutcomesStroke, 2012
- The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical prioritiesEuropean Heart Journal, 2011
- Combined Intravenous and Intra-Arterial Recanalization for Acute Ischemic Stroke: The Interventional Management of Stroke StudyStroke, 2004
- Composite Outcomes in Randomized TrialsJAMA, 2003
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)The Lancet, 1998